Literature DB >> 15662611

New perspectives on von Willebrand factor functions in hemostasis and thrombosis.

Grazia Loredana Mendolicchio1, Zaverio M Ruggeri.   

Abstract

The adhesive protein, von Willebrand factor (VWF), mediates the initiation and progression of thrombus formation at sites of vascular injury by means of specific interactions with extracellular matrix components and platelet receptors. The essential biologic properties of VWF have been elucidated, with progress particularly in the areas of genetic regulation, biosynthesis, and specific bimolecular interactions. The three-dimensional structure of selected domains has been solved, but our understanding of detailed structure-function relationships is still fragmented, partly because of the complexity and size of the VWF molecule. The biomechanical properties of the interaction between the VWF A1 domain and the platelet receptor glycoprotein (GP) Ibalpha also are better known, but we can still only hypothesize how this adhesive bond can oppose the fluid dynamic effects of rapidly flowing blood to initiate thrombus formation and contribute to platelet activation. Elucidating the details of VWF and GPIbalpha function will lead to a more satisfactory definition of the role of platelets in atherothrombosis, since hemodynamic forces greatly influence responses to vascular injury in stenosed and partially occluded arteries. Progress in this direction is also aided by rapidly expanding novel information on the mechanisms that regulate VWF multimer size in the circulation, a topic of relevance to explain microvascular thrombosis and, perhaps, arterial thrombosis in general. Developments in these areas of research will refine our understanding of the role played by VWF in vascular biology and pathology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15662611     DOI: 10.1053/j.seminhematol.2004.09.006

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  15 in total

1.  The role of von Willebrand factor and ADAMTS13 in the no-reflow phenomenon: after primary percutaneous coronary intervention.

Authors:  Bilian Zhao; Jian Li; Xinping Luo; Qing Zhou; Hua Chen; Haiming Shi
Journal:  Tex Heart Inst J       Date:  2011

2.  Circulating but not immobilized N-deglycosylated von Willebrand factor increases platelet adhesion under flow conditions.

Authors:  M A Fallah; V Huck; V Niemeyer; A Desch; J I Angerer; T A J McKinnon; A Wixforth; S W Schneider; M F Schneider
Journal:  Biomicrofluidics       Date:  2013-08-26       Impact factor: 2.800

Review 3.  The role of von Willebrand factor in thrombus formation.

Authors:  Zaverio M Ruggeri
Journal:  Thromb Res       Date:  2007-05-09       Impact factor: 3.944

4.  The influence of vasovagal response on the coagulation system.

Authors:  Markus Kraemer; Markus Kuepper; Andrea Nebe-vom Stein; Ulrich Sorgenfrei; Rolf R Diehl
Journal:  Clin Auton Res       Date:  2009-07-25       Impact factor: 4.435

5.  Identification of extant vertebrate Myxine glutinosa VWF: evolutionary conservation of primary hemostasis.

Authors:  Marianne A Grant; David L Beeler; Katherine C Spokes; Junmei Chen; Harita Dharaneeswaran; Tracey E Sciuto; Ann M Dvorak; Gianluca Interlandi; José A Lopez; William C Aird
Journal:  Blood       Date:  2017-09-12       Impact factor: 22.113

6.  Platelet adhesive dynamics. Part II: high shear-induced transient aggregation via GPIbalpha-vWF-GPIbalpha bridging.

Authors:  Nipa A Mody; Michael R King
Journal:  Biophys J       Date:  2008-05-30       Impact factor: 4.033

7.  Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor.

Authors:  Simon F De Meyer; Karen Vanhoorelbeke; Marinee K Chuah; Inge Pareyn; Veerle Gillijns; Robert P Hebbel; Désiré Collen; Hans Deckmyn; Thierry VandenDriessche
Journal:  Blood       Date:  2006-02-14       Impact factor: 22.113

8.  Contrast-enhanced ultrasound molecular imaging of activated platelets in the progression of atherosclerosis using microbubbles bearing the von Willebrand factor A1 domain.

Authors:  Jie Tian; Yahui Weng; Ruiying Sun; Ying Zhu; Jun Zhang; Hongyun Liu; Yani Liu
Journal:  Exp Ther Med       Date:  2021-05-03       Impact factor: 2.447

9.  What a polyclonal antibody sees in von Willebrand factor.

Authors:  Fen-Lai Tan; David Ginsburg
Journal:  Thromb Res       Date:  2007-07-05       Impact factor: 3.944

10.  Terminal platelet production is regulated by von Willebrand factor.

Authors:  Sonia Poirault-Chassac; Kim Anh Nguyen; Audrey Pietrzyk; Caterina Casari; Agnes Veyradier; Cecile V Denis; Dominique Baruch
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.